As previously reported, Scotiabank initiated coverage of Thermo Fisher Scientific (TMO), Danaher (DHR), Waters Corporation (WAT), all with Sector Perform ratings, and price targets of $605, $265 and $430, respectively. The firm’s long-term outlook for the life science tools sector “has been and remains bullish,” and it views the three stocks as “some of the highest-quality stocks to own.” However, in the near term, the firm is more neutral on these large cap names given continued end-market uncertainties, particularly with biopharma and China, and, to a lesser extent, any political uncertainties exiting 2024, the analyst tells investors.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DHR:
- Danaher initiated with a Sector Perform at Scotiabank
- Danaher initiated with a Buy at Guggenheim
- Danaher upgraded to Buy at BofA following pullback
- Danaher upgraded to Buy from Neutral at BofA
- Danaher put volume heavy and directionally bearish
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
